Nanopharmaceuticals Market, By Carrier Type (Liposomes, Polymer, Nanocrystals, Inorganic, Protein, and Others), Application (Oncology, Neurology, Anti-Inflammatory, Anti-Infective, Cardiovascular, and Others), End User (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and the Rest of the World) – Market Size & Forecasting (2016-2028)

The global nanopharmaceuticals market size was valued at USD 29.4 billion in 2018 and is anticipated to grow at a CAGR of 20.3% during the forecast period. Nanopharmaceuticals comprised of active molecules or biological substances that are prepared primarily for improving the drug therapies through attenuating toxicity profiles and safety concerns, or in vivo imaging. Also, it enhances the early detection of diseases and further implement diagnostic applications based on effective conventional procedures using nanoparticles. Additionally, it represents as an emerging field in the global market, where it articulated as nanoscale of the drug particle or a therapeutic delivery system. It is widely adopted in the medical procedures to rectify the disease at much higher speed, in the pharmaceutical industry. It also removes the toxic systemic side effects to result in better patient compliance.

Nanopharmaceuticals Market stats

Nanopharmaceuticals Market Statistics

Considering the current market scenario, the pharmaceutical industry is primarily facing enormous pressure to meet the requirement for high-quality difficult diseases such as cancer and neurological diseases among others along with maintaining profitability. Moreover, the increase in neurodegenerative diseases in the global market primarily influences the demand for nanopharmaceuticals in the market during the forecast period. The advancement in nanotechnology owing to the heavy investment from the pharmaceutical companies is further lead to the growth of the market. The nanopharmaceuticals has a high success rate and due to the faster introduction of new and cost-effective products are expected to create investment opportunities from the private and government companies, which further increase the demand and sales in the market.

However, the high price of the technology and lack of regulatory guidelines in the global market are expected to hinder the growth of the market during the forecast period.

Key Factors Impacting the Growth of Nanopharmaceuticals Market:

  • Increase the incidences of neurodegenerative diseases.
  • Furthermore, increasing research and development activities are expected to drive the U.S. nanopharmaceuticals market growth.

Nanopharmaceuticals Market Segments

Nanopharmaceuticals Market By Segmentation (2017-2028)

The nanopharmaceuticals market segmentation is based on carrier type, application, end user, and region.

Carrier Type Outlook:

Based on carrier type, the market has been segmented into liposomes, polymer, nanocrystals, inorganic, protein, and others. The liposomes segment is expected to dominate the market in 2018 and further expected to lead the market during the forecast period.

Application Outlook

Based on the application, the market is segmented into oncology, neurology, anti-inflammatory, anti-infective, cardiovascular, and others. The oncology segment is expected to dominate the market in 2018 due to the increasing incidence of serious diseases such as cancer.

End User Outlook:

Based on end user, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is expected to lead the market in 2018 owing to increase investment from the pharmaceutical and government authorities to meet the demand from the consumers.

Nanopharmaceuticals Market Region

Nanopharmaceuticals Market By Regional Analysis (2017-2028) 

Regional Outlook:

Based on the region, the global nanopharmaceuticals market has been segmented by North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, & Rest of the World. In terms of value, North America holds the highest market share in the global nanopharmaceuticals market in 2018 and further expected to continue its dominance over the forecast period. The increase in government spending in the research and development activities to enhance the adoption of nanotechnology and the rise in growth of chronic diseases are further expected to lead the growth of the market in the region. Moreover, Asia-Pacific is expected to hold the highest growth rate in the market during the forecast period owing to the increase in awareness for medical treatment.

Competitive Landscape

The main manufacturing companies operating in the nanopharmaceuticals market are primarily focused on new product development strategies and increase its investment for research and development activities that in turn is expected to propel the market growth over the forecast period. The key leading players in the market include Abbott, GlaxoSmithKline plc., Eli Lilly and Company, Stryker Corporation, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Tanabe Pharma Corporation, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Navidea Biopharmaceuticals, Inc., Astrazeneca plc., Novavax, Inc., AMAG Pharmaceuticals, Amgen Inc., Celgene Corporation, Gilead Sciences, Inc., JOHNSON & JOHNSON, Novartis AG, Hoffmann-La Roche AG, Sanofi S.A, and Teva Pharmaceuticals Industries Limited.

This report also includes the profiles of key nanopharmaceuticals market companies along with their SWOT analysis and market strategies. In addition, these competitive landscapes provide a detailed description of each company including future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launch, new product developments, and other latest industrial developments.

Key Developments in Nanopharmaceuticals Market:

  • In October 2019, The Union Minister of India for Science & Technology, Earth Sciences and Health & Family Welfare launched the guidelines for evaluation of nanopharmaceuticals in India.
  • In October 2019, The Government of India introduced new regulatory guidelines to enhance and indorse the demand for nano-pharmaceuticals in the country.
  • According to the European Union, the government strategies to increase the production of nanopharmaceuticals from pre-clinical laboratory and introduced GMP quality for clinical testing to improve manufacturing capacity and supply infrastructure.

Nanopharmaceuticals Market

Nanopharmaceuticals Market Timeline (2017-2028)

What Does This Report Provide?

This report provides a detailed understanding of the global nanopharmaceuticals market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Carrier Type

  • Liposomes
  • Polymer
  • Nanocrystals
  • Inorganic
  • Protein
  • Others

By Application

  • Oncology
  • Neurology
  • Anti-Inflammatory
  • Anti-Infective
  • Cardiovascular
  • Others

By End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

North America

  • By Country (US, Canada, Mexico)
  • By Carrier Type
  • By Application
  • By End User

Western Europe

  • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
  • By Carrier Type
  • By Application
  • By End User

Eastern Europe

  • By Country (Russia, Turkey, Rest of Eastern Europe)
  • By Carrier Type
  • By Application
  • By End User

Asia Pacific

  • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
  • By Carrier Type
  • By Application
  • By End User

Middle East

  • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
  • By Carrier Type
  • By Application
  • By End User

Rest of the World

  • By Region (South America, Africa)
  • By Carrier Type
  • By Application
  • By End User

Reasons to Buy This Report:

  • Market size estimation of the nanopharmaceuticals market on a regional and global basis
  • Unique research Usage for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: sales@quincemarketinsights.com